Award

National Institute of Neurological Disorders and Stroke 5R01NS132780-03

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Recipient

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

Award Amount

$636,772.00

Ceiling

$636,772.00

Awarded

August 15, 2025

Identifier

5R01NS132780-03

Research project funded by NIH/NINDS investigating the role of ecDNA in medulloblastoma to understand tumor heterogeneity and treatment resistance, aiming to develop novel therapeutic strategies.

Description

The project focuses on extrachromosomal DNA (ecDNA) in medulloblastoma to understand tumor heterogeneity and treatment resistance using novel computational and imaging methods. It includes multiple aims: molecular evolution of ecDNA, combinatorial therapies, and functional inhibition. The research addresses limitations of current standard treatments for medulloblastoma.

View original record